Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Behavior
- Sponsor
- Tulane University
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Difference in Percent of Participants Completing Colorectal Cancer Screening Between Study Arms
- Status
- Completed
- Last Updated
- 12 months ago
Overview
Brief Summary
The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are:
- Do patient financial incentives for completing colorectal cancer screening increase screening completion?
- Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots?
Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment.
Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 45 to 75
- •Receive care at participating primary care clinic
- •Due for colorectal cancer screening
- •Ability to understand and speak English
Exclusion Criteria
- •Currently participating in another clinical trial or research study on colorectal cancer screening
- •Unable or unwilling to give informed consent
Outcomes
Primary Outcomes
Difference in Percent of Participants Completing Colorectal Cancer Screening Between Study Arms
Time Frame: Two months
Completion of colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test as documented in electronic health record within two months of study enrollment
Secondary Outcomes
- Difference in Percent of Participants Completing COVID-19 Shot Between Study Arms(Two months)
- Difference in Percent of Participants Completing Flu Shot Between Study Arms(Two months)
- Difference in Percent of Participants Completing at Least One of the Following Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot(Two months)
- Difference in Percent of Participants Completing All Three Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot(Two months)